Updated COVID-19 XBB.1.5 vaccines elicit strong immune responses to new SARS-CoV-2 variants

Two new studies on SARS-CoV-2 vaccine immune responses suggest that the XBB.1.5-containing mRNA vaccines most likely increase protection against COVID-19 caused by currently circulating XBB variants ...

EUROIMMUN’s portfolio for therapeutic drug monitoring is expanding

EUROIMMUN has been offering test systems for therapeutic drug monitoring (TDM) since 2019. Owing to the cooperation with IDS and their range of TDM products from Theradiag, we were able to ...

Immunoblots: an old friend with a new face – An interview with EUROIMMUN

Ultrafast immunofluorescence microscopy – now with 89 new products for autoimmune and infection diagnostics

Pump It Up: Vascular Disease Awareness

Vascular diseases encompass a wide range of conditions that affect the blood vessels, impacting their function and structure. These conditions can be life-threatening if left untreated, and yet many ...

First newly developed ELISA of risk class B declared IVDR-compliant

After EUROIMMUN received the required certificate for its quality management system in accordance with the new European Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) in May of ...

Dried blood spots provide easy, reliable antibody testing

Dried blood spots (DBS) collected from the fingertip yield reliable results in analysis of anti-SARS-CoV-2 antibodies, even after prolonged storage of DBS eluates for 6 to 8 hours. This was ...

Omicron-induced T- and B-cell immunity in vaccinated and naïve individuals

A recent study has demonstrated substantial differences in SARS-CoV-2 immunity after Omicron infection in triple-COVID-19-vaccinated and antigen-naïve individuals, which may influence cross-protection ...

Schleswig-Holstein’s Minister of Economic Affairs visits EUROIMMUN

Claus Ruhe Madsen, Minister of Economic Affairs, Transport, Employment, Technology and Tourism of the German state of Schleswig-Holstein, together with Dr. Jürgen Walkenhorst and Dr. Georg Eschenburg ...

A life-saving diagnosis thanks to comprehensive antibody testing – a motivating success story

In our latest video, Mr Mende tells us how autoantibody determination completely changed his prognosis. For the past six years, Mr Mende has suffered from necrotising myositis, an autoimmune disease ...

Back to top